BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6608403)

  • 1. Indirect stimulation of B-cell proliferation in vitro by T cells, as evidenced by cytogenetic analysis of PHA-stimulated cell cultures of B-cell lymphomas.
    Vermaelen K; Barbieri D; Van den Berghe H
    Cancer Genet Cytogenet; 1984 Apr; 11(4):425-8. PubMed ID: 6608403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
    Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
    Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies of lymph nodes infiltrated by non-Hodgkin's lymphoma.
    Al-Irhayim B
    Diagn Histopathol; 1981; 4(2):137-48. PubMed ID: 7261859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T or B cell origin of some non-Hodgkin's lymphomas.
    Peter CR; MacKenzie MR; Glassy FJ
    Lancet; 1974 Sep; 2(7882):686-9. PubMed ID: 4142961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro.
    Mangge H; Beaufort F; Neubauer M; Samitz M; Schauenstein K
    Cancer; 1990 Aug; 66(4):677-83. PubMed ID: 2386899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony formation by normal and malignant human B-lymphocytes.
    Izaguirre CA; Minden MD; Howatson AF; McCulloch EA
    Br J Cancer; 1980 Sep; 42(3):430-7. PubMed ID: 6968572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies.
    Coccia PF
    Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518
    [No Abstract]   [Full Text] [Related]  

  • 13. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
    Robert KH
    Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells.
    Ostlund L; Biberfeld P; Robèrt KH; Christensson B; Einhorn S
    Blood; 1989 Jun; 73(8):2171-81. PubMed ID: 2471560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative proportions of mitotic T and B cells in PHA-stimulated lymphocyte cultures.
    Knuutila S; Kovanen PE
    Cancer Genet Cytogenet; 1987 Nov; 29(1):151-4. PubMed ID: 3499214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantation.
    Nozawa Y; Abe M; Wakasa H; Ohno H; Fukuhara S; Kinoshita T; Osato T
    Tohoku J Exp Med; 1988 Dec; 156(4):319-30. PubMed ID: 2854303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood and bone marrow involvement by non-Hodgkin's lymphoma: morphological, immunological and cytochemical features.
    Cousar JB; Glick AD; York JC; Miers M; Collins RD
    Prog Clin Pathol; 1984; 9():173-96. PubMed ID: 6364222
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth factor-mediated proliferation in B cell non-Hodgkin's lymphomas.
    Ford RJ; Kouttab NM; Sahasrabuddhe CG; Davis FM; Mehta SR
    Blood; 1985 Jun; 65(6):1335-41. PubMed ID: 3873263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHA reactivity of spontaneous AKR lymphomas: absolute macrophage requirement.
    Alonso MC; Solana R; Torres A; de la Fuente M; Peña J
    Allergol Immunopathol (Madr); 1984; 12(5):363-7. PubMed ID: 6335356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.